Effect of bethanechol, neostigmine, metoclopramide, and propranolol on myoelectric activity of the ileocecocolic area in cows.
The effect of bethanechol, neostigmine, metoclopramide, and propranolol on myoelectric activity of the ileum, cecum, and proximal loop of the ascending colon was determined in 6 healthy Jersey cows implanted with 8 pairs of bipolar electrodes. Assigned at random, each cow received each of 5 treatments in 3-day intervals. The treatments included bethanechol (0.07 mg/kg of body weight, SC), neostigmine (0.02 mg/kg, SC), metoclopramide (0.15 mg/kg, IM), DL-propranolol (0.2 mg/kg, IM), and 0.9% sodium chloride (NaCl) solution (20 ml, SC). All drugs were administered during early phase I of the migrating myoelectric complex in the ileum. Myoelectric activity was recorded for 4 hours after treatment, and data were analyzed for each hour separately. Bethanechol and neostigmine significantly (P < 0.05) increased the number of cecocolic spikes per minute per electrode, duration of cecocolic spike activity (%), and number of cecocolic propagated spike sequences per 10 minutes, relative to NaCl, during 1 or more hours of the recording period. The effect of bethanechol was more pronounced on duration of spike activity and number of propagated spike sequences, whereas neostigmine mainly increased the number of (uncoordinated) spikes. Metoclopramide and propranolol had no significant effect on cecocolic myoelectric activity, relative to NaCl. It was concluded that bethanechol and, less likely, neostigmine at the dosage used in this study may be suitable for medical treatment of cecal dilatation in cattle in which hypomotility of the cecum and proximal loop of the ascending colon has to be reversed. The potential advantage of bethanechol vs neostigmine for medical treatment of cecal dilatation is worth further evaluation.
Steiner
A
A
Clinic for Food Animals and Horses, University of Bern, Switzerland.
Roussel
A J
AJ
Martig
J
J
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000704:Analysis of Variance; D000818:Animals; D018723:Bethanechol / Q000494:pharmacology*; D002417:Cattle; D002432:Cecum / Q000187:drug effects; D018678:Cholinergic Agents / Q000494:pharmacology*; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D003106:Colon / Q000187:drug effects; D018492:Dopamine Antagonists / Q000494:pharmacology*; D005260:Female; D007082:Ileum / Q000187:drug effects; D007422:Intestines / Q000187:drug effects*; D008787:Metoclopramide / Q000494:pharmacology*; D018721:Muscarinic Agonists / Q000494:pharmacology; D016065:Myoelectric Complex, Migrating / Q000187:drug effects*; D009388:Neostigmine / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology*
D000319:Adrenergic beta-Antagonists; D018678:Cholinergic Agents; D002800:Cholinesterase Inhibitors; D018492:Dopamine Antagonists; D018721:Muscarinic Agonists; D018723:Bethanechol; D009388:Neostigmine; D011433:Propranolol; D008787:Metoclopramide